Navigation Links
Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card
Date:11/23/2009

SAN DIEGO, Nov. 23 /PRNewswire/ -- Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.

NAPRELAN Dose Card is designed for patients who require relief from mild to moderate pain and inflammation associated with primary dysmenorrhea and acute tendinitis and bursitis. It is also designed for patients suffering from rheumatoid arthritis or osteoarthritis who may be receiving other therapies and need additional anti-inflammatory/analgesic activity for a limited time. The Dose Card provides a ten day, tapered dose regimen in a single blister pack, with three days of NAPRELAN therapy at the maximum daily dose of 1,500 mg (i.e., two 750 mg tablets), followed by a taper to 1,000 mg per day (two 500 mg tablets) for an additional seven days of therapy.

Commenting on NAPRELAN Dose Card, Victory's Chief Executive Officer Matthew Heck stated, "This product concept is the result of substantial input from our clinical advisors and other members of the pain management community. It was designed to enable healthcare providers to treat pain and inflammation aggressively for a limited period of time and then taper NAPRELAN back to a standard dosage strength. This customized dosage regimen in a single prescription and product configuration will aid in patient compliance. We are excited about the prospects for NAPRELAN Dose Card based upon market feedback."

Victory will promote NAPRELAN Dose Card through its 160 person U.S. field sales organization.

About Victory Pharma

Founded in 2003, Victory Pharma, Inc. is a privately held specialty pharmaceutical company headquartered in San Diego, CA focused on acquiring, developing, and marketing products to treat pain and related conditions. Victory markets its lead product, NAPRELAN® (naproxen sodium) Controlled-Release Tablets and other pain products to pain management specialists, rheumatologists, orthopedic surgeons, and selected primary care physicians through its physician office-based field sales force. Victory is also developing proprietary products for the treatment of chronic pain and common opioid-induced side effects. Further information regarding Victory Pharma is available at www.victorypharma.com.

NAPRELAN ® is a trademark of Elan Corporation, plc.

SOURCE Victory Pharma, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers notch a victory toward new kind of cancer drug
2. Stupak Amendment Passes in Final House Health Care Bill. A First Step to Victory, but Many Battles Ahead. We Must Rejoice With Caution.
3. Connecticut Cigarette Tax Increase Delivers Victory for Kids and Taxpayers; $1 Increase Gives State Second Highest Cigarette Tax in the Nation
4. Mother & Daughter Celebrate Victory Over Meth
5. District of Columbia Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
6. Victory Pharma, Inc. Announces FDA Accepts MGX006 NDA for Review
7. President Obama Delivers Historic Victory for Americas Kids and Health over Tobacco
8. American College of Chest Physicians Celebrates the Nations Victory for Tobacco Control
9. Mississippi Tobacco Tax Increase is a Victory for Kids and Taxpayers
10. Victory! Colombian Government Cuts Price of Abbotts Lifesaving AIDS Drug Kaletra 55%, Says AHF
11. Hawaii Cigarette Tax Increase Delivers Victory for Kids and Taxpayers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The ... consultations to communities in the greater Denver region, is announcing a charity drive ... a very rare kind of epilepsy. , Until a few months ago, Dominik ...
(Date:7/21/2017)... Grove, Ill. (PRWEB) , ... July 21, 2017 , ... ... & Fabric Liquid eco-friendly odor-control solution for colleges and universities at the ... safely and effectively eliminate severe cannabis and tobacco smoke odors without the use of ...
(Date:7/21/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has written a new ... pleads with world leaders to be more open about positive changes. Yisrayl says the use ... is a peaceful and positive way to solve all; yes, all issues, and he is ...
(Date:7/21/2017)... , ... July 21, 2017 , ... West Dermatology is ... Doan Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large ... of experience in dermatology, skin cancer , and more. She graduated from the ...
(Date:7/20/2017)... Va. (PRWEB) , ... July 20, 2017 , ... ... McCarter, MD, has joined JenCare Senior Medical Center as Richmond Chief Medical ... Virginia School of Medicine, and Associate Chief Medical Officer of Ambulatory Services for the ...
Breaking Medicine News(10 mins):
(Date:7/17/2017)... -- MedX Holdings, Inc., the manufacturer and global distributor of ... today announced the national roll out of its MedX ... standard for the treatment of low back injuries and ... How it works: MedX ... who prescribe the MedX Home Back Machine Program for ...
(Date:7/14/2017)... July 13, 2017 It should come as no ... is in the midst of a crippling opioid epidemic. ... 1999, the number of overdose deaths from opiate-based medications has ... half a million dead from 2001 to 2015". During this ... hydrocodone has similarly quadrupled, drawing a compelling link between prescription ...
(Date:7/13/2017)... Md. , July 13, 2017  New York City-based ... of pharmaceutical markets should be aware of.  From new products ... trends are detailed in a recently completed study, Potential ... 1.  Age-Driven Growth ... we have been aware of the impact the growing population ...
Breaking Medicine Technology: